Tetramethylpyrazine ameliorates metabolic dysfunction-associated steatohepatitis by modulating gut microbiota dysbiosis and restoring intestinal barrier integrity.
- DOI
- 10.1111/bph.70640
- Published
- 2026 Sep 10
- Container
- British journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bph.70640,
title = {Tetramethylpyrazine ameliorates metabolic dysfunction-associated steatohepatitis by modulating gut microbiota dysbiosis and restoring intestinal barrier integrity.},
author = {He X and Zhang L and Zhu Y and Liu W and You J and Chen W and Fu X and Yang S and Shao Y and Hu Y and Li Y and Zheng M and Yang H and Ge G and Yao Z and He Y},
year = {2026},
journal = {British journal of pharmacology},
doi = {10.1111/bph.70640},
url = {https://doi.org/10.1111/bph.70640}
}RIS
TY - JOUR TI - Tetramethylpyrazine ameliorates metabolic dysfunction-associated steatohepatitis by modulating gut microbiota dysbiosis and restoring intestinal barrier integrity. AU - He X AU - Zhang L AU - Zhu Y AU - Liu W AU - You J AU - Chen W AU - Fu X AU - Yang S AU - Shao Y AU - Hu Y AU - Li Y AU - Zheng M AU - Yang H AU - Ge G AU - Yao Z AU - He Y PY - 2026 JO - British journal of pharmacology DO - 10.1111/bph.70640 UR - https://doi.org/10.1111/bph.70640 ER -
APA
X, H., L, Z., Y, Z., W, L., J, Y., W, C., X, F., S, Y., Y, S., Y, H., Y, L., M, Z., H, Y., G, G., Z, Y., & Y, H. (2026). Tetramethylpyrazine ameliorates metabolic dysfunction-associated steatohepatitis by modulating gut microbiota dysbiosis and restoring intestinal barrier integrity.. British journal of pharmacology. https://doi.org/10.1111/bph.70640
Source records
- pubmed · retrieved 2026-09-25T10:32:37.647Z